Santiago Vernia

Santiago Vernia

Auto-generated profile, based on publicly available information

Santiago Vernia

MRC London Institute of Medical Sciences, London, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
AGAna Guerrero
Ana Guerrero
NHNicolás Herranz
Nicolás Herranz
BSBin Sun
Bin Sun
VWVerena Wagner
Verena Wagner
SGSuchira Gallage
Suchira Gallage
JGJesús Gil
Jesús Gil

1 September 2014 in Cell Metabolism
Verified
Journal Article
Closed access
SVSantiago Vernia
Santiago Vernia
JCJulie Cavanagh-Kyros
Julie Cavanagh-Kyros
LGLuisa Garcia-Haro
Luisa Garcia-Haro
GSGuadalupe Sabio
Guadalupe Sabio
TBTamera Barrett
Tamera Barrett
RDRoger J. Davis
Roger J. Davis

21 April 2016 in Nature Communications
Verified
Journal Article
Open access
YTYuefeng Tang
Yuefeng Tang
Martina WallaceMartina Wallace
Martina Wallace
JSJoan Sanchez-Gurmaches
Joan Sanchez-Gurmaches
WHWen-Yu Hsiao
Wen-Yu Hsiao
HLHuawei Li
Huawei Li
DGDavid A. Guertin
David A. Guertin
Adipose tissue de novo lipogenesis (DNL) positively influences insulin sensitivity, is reduced in obesity, and predicts insulin resistance. Therefore, elucidating mechanisms controlling adipose tissue DNL could lead to therapies for type 2 diabetes. Here, we report that mechanistic target of rapamycin complex 2 (mTORC2) functions in white adipose tissue (WAT) to control expression of the lipogenic transcription factor ChREBPβ. Conditionally deleting the essential mTORC2 subunit Rictor in mature adipocytes decreases ChREBPβ expression, which reduces DNL in WAT, and impairs hepatic insulin sensitivity. Mechanistically, Rictor/mTORC2 promotes ChREBPβ expression in part by controlling glucose uptake, but without impairing pan-AKT signalling. High-fat diet also rapidly decreases adipose tissue ChREBPβ expression and insulin sensitivity in wild-type mice, and does not further exacerbate insulin resistance in adipose tissue Rictor knockout mice, implicating adipose tissue DNL as an early target in diet-induced insulin resistance. These data suggest mTORC2 functions in WAT as part of an extra-hepatic nutrient-sensing mechanism to control glucose homeostasis.

7 May 2010 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
CACarmen Aguado
Carmen Aguado
SSSovan Sarkar
Sovan Sarkar
VKViktor Korolchuk
Viktor Korolchuk
OCOlga Criado
Olga Criado
SVSantiago Vernia
Santiago Vernia
DRDavid C. Rubinsztein
David C. Rubinsztein
Lafora disease (LD) is an autosomal recessive, progressive myoclonus epilepsy, which is characterized by the accumulation of polyglucosan inclusion bodies, called Lafora bodies, in the cytoplasm of cells in the central nervous system and in many other organs. However, it is unclear at the moment whether Lafora bodies are the cause of the disease, or whether they are secondary consequences of a primary metabolic alteration. Here we describe that the major genetic lesion that causes LD, loss-of-function of the protein laforin, impairs autophagy. This phenomenon is confirmed in cell lines from human patients, mouse embryonic fibroblasts from laforin knockout mice and in tissues from such mice. Conversely, laforin expression stimulates autophagy. Laforin regulates autophagy via the mammalian target of rapamycin kinase-dependent pathway. The changes in autophagy mediated by laforin regulate the accumulation of diverse autophagy substrates and would be predicted to impact on the Lafora body accumulation and the cell stress seen in this disease that may eventually contribute to cell death.

20 December 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
OCOlga Criado
Olga Criado
CACarmen Aguado
Carmen Aguado
JGJavier Gayarre
Javier Gayarre
LDLara Duran-Trio
Lara Duran-Trio
AGAna M. Garcia-Cabrero
Ana M. Garcia-Cabrero
SCSantiago Rodríguez De Córdoba
Santiago Rodríguez De Córdoba
Lafora disease (LD), a fatal neurodegenerative disorder characterized by the presence of intracellular inclusions called Lafora bodies (LBs), is caused by loss-of-function mutations in laforin or malin. Previous studies suggested a role of these proteins in the regulation of glycogen biosynthesis, in glycogen dephosphorylation and in the modulation of the intracellular proteolytic systems. However, the contribution of each of these processes to LD pathogenesis is unclear. We have generated a malin-deficient (Epm2b−/−) mouse with a phenotype similar to that of LD patients. By 3–6 months of age, Epm2b−/− mice present neurological and behavioral abnormalities that correlate with a massive presence of LBs in the cortex, hippocampus and cerebellum. Sixteen-day-old Epm2b−/− mice, without detectable LBs, show an impairment of macroautophagy (hereafter called autophagy), which remains compromised in adult animals. These data demonstrate similarities between the Epm2a−/− and Epm2b−/− mice that provide further insights into LD pathogenesis. They illustrate that the dysfunction of autophagy is a consequence of the lack of laforin–malin complexes and a common feature of both mouse models of LD. Because this dysfunction precedes other pathological manifestations, we propose that decreased autophagy plays a primary role in the formation of LBs and it is critical in LD pathogenesis.

16 September 2016 in eLife
Verified
Journal Article
Open access
SVSantiago Vernia
Santiago Vernia
YEYvonne Edwards
Yvonne Edwards
HKHyeon Soo Kim
Hyeon Soo Kim
JCJulie Cavanagh-Kyros
Julie Cavanagh-Kyros
TBTamera Barrett
Tamera Barrett
RDRoger J Davis
Roger J Davis
Alternative pre-mRNA splicing expands the complexity of the transcriptome and controls isoform-specific gene expression. Whether alternative splicing contributes to metabolic regulation is largely unknown. Here we investigated the contribution of alternative splicing to the development of diet-induced obesity. We found that obesity-induced changes in adipocyte gene expression include alternative pre-mRNA splicing. Bioinformatics analysis associated part of this alternative splicing program with sequence specific NOVA splicing factors. This conclusion was confirmed by studies of mice with NOVA deficiency in adipocytes. Phenotypic analysis of the NOVA-deficient mice demonstrated increased adipose tissue thermogenesis and improved glycemia. We show that NOVA proteins mediate a splicing program that suppresses adipose tissue thermogenesis. Together, these data provide quantitative analysis of gene expression at exon-level resolution in obesity and identify a novel mechanism that contributes to the regulation of adipose tissue function and the maintenance of normal glycemia.